IBERSOL SGPS SA (IBS.LS) Stock Fundamental Analysis
Europe - Euronext Lisbon - ELI:IBS - PTIBS0AM0008 - Common Stock
9.9 EUR
+0.02 (+0.2%)
Overall IBS gets a fundamental rating of 4 out of 10. We evaluated IBS against 55 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of IBS is average, but there are quite some concerns on its profitability. IBS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year IBS was profitable.
In the past year IBS had a positive cash flow from operations.
Of the past 5 years IBS 4 years were profitable.
IBS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
IBS has a Return On Assets of 1.90%. This is in the lower half of the industry: IBS underperforms 65.45% of its industry peers.
With a Return On Equity value of 4.18%, IBS perfoms like the industry average, outperforming 50.91% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.59%, IBS is doing worse than 63.64% of the companies in the same industry.
IBS had an Average Return On Invested Capital over the past 3 years of 3.35%. This is significantly below the industry average of 12.63%.
The last Return On Invested Capital (4.59%) for IBS is above the 3 year average (3.35%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.9% | ||
| ROE | 4.18% | ||
| ROIC | 4.59% |
ROA(3y)9.48%
ROA(5y)5.16%
ROE(3y)16.66%
ROE(5y)5.67%
ROIC(3y)3.35%
ROIC(5y)N/A
1.3 Margins
IBS has a worse Profit Margin (2.54%) than 63.64% of its industry peers.
In the last couple of years the Profit Margin of IBS has declined.
With a Operating Margin value of 5.90%, IBS is not doing good in the industry: 61.82% of the companies in the same industry are doing better.
IBS's Operating Margin has declined in the last couple of years.
IBS has a Gross Margin (52.66%) which is in line with its industry peers.
IBS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.9% | ||
| PM (TTM) | 2.54% | ||
| GM | 52.66% |
OM growth 3Y-39.59%
OM growth 5Y-6.37%
PM growth 3Y-42.29%
PM growth 5Y-3.98%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IBS is destroying value.
The number of shares outstanding for IBS remains at a similar level compared to 1 year ago.
The number of shares outstanding for IBS has been increased compared to 5 years ago.
The debt/assets ratio for IBS is higher compared to a year ago.
2.2 Solvency
IBS has an Altman-Z score of 2.09. This is not the best score and indicates that IBS is in the grey zone with still only limited risk for bankruptcy at the moment.
IBS's Altman-Z score of 2.09 is in line compared to the rest of the industry. IBS outperforms 54.55% of its industry peers.
IBS has a debt to FCF ratio of 3.47. This is a good value and a sign of high solvency as IBS would need 3.47 years to pay back of all of its debts.
IBS has a better Debt to FCF ratio (3.47) than 67.27% of its industry peers.
IBS has a Debt/Equity ratio of 0.66. This is a neutral value indicating IBS is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.66, IBS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 3.47 | ||
| Altman-Z | 2.09 |
ROIC/WACC0.73
WACC6.28%
2.3 Liquidity
IBS has a Current Ratio of 1.02. This is a normal value and indicates that IBS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.02, IBS is in line with its industry, outperforming 60.00% of the companies in the same industry.
IBS has a Quick Ratio of 1.02. This is a bad value and indicates that IBS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.92, IBS perfoms like the industry average, outperforming 56.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.02 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
IBS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.44%.
Measured over the past years, IBS shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.23% on average per year.
Looking at the last year, IBS shows a quite strong growth in Revenue. The Revenue has grown by 15.00% in the last year.
The Revenue has been decreasing by -0.46% on average over the past years.
EPS 1Y (TTM)-16.44%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%83.33%
Revenue 1Y (TTM)15%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%7.53%
3.2 Future
Based on estimates for the next years, IBS will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.57% on average per year.
IBS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.42% yearly.
EPS Next Y-25.98%
EPS Next 2Y4.99%
EPS Next 3Y10.92%
EPS Next 5Y17.57%
Revenue Next Year15.95%
Revenue Next 2Y10.49%
Revenue Next 3Y8.64%
Revenue Next 5Y7.42%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
IBS is valuated quite expensively with a Price/Earnings ratio of 29.12.
IBS's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.77. IBS is around the same levels.
Based on the Price/Forward Earnings ratio of 28.01, the valuation of IBS can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IBS is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.35. IBS is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.12 | ||
| Fwd PE | 28.01 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, IBS is valued cheaper than 83.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.95 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.99%
EPS Next 3Y10.92%
5. Dividend
5.1 Amount
IBS has a Yearly Dividend Yield of 7.07%, which is a nice return.
Compared to an average industry Dividend Yield of 1.40, IBS pays a better dividend. On top of this IBS pays more dividend than 100.00% of the companies listed in the same industry.
IBS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.07% |
5.2 History
On average, the dividend of IBS grows each year by 48.99%, which is quite nice.
Dividend Growth(5Y)48.99%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IBS pays out 218.70% of its income as dividend. This is not a sustainable payout ratio.
IBS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP218.7%
EPS Next 2Y4.99%
EPS Next 3Y10.92%
ELI:IBS (12/30/2025, 7:00:00 PM)
9.9
+0.02 (+0.2%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners21.5%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap410.95M
Revenue(TTM)522.66M
Net Income(TTM)13.26M
Analysts83.33
Price Target11.92 (20.4%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.07% |
Yearly Dividend0.5
Dividend Growth(5Y)48.99%
DP218.7%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.11%
Min Revenue beat(2)-3.41%
Max Revenue beat(2)-0.81%
Revenue beat(4)2
Avg Revenue beat(4)4.87%
Min Revenue beat(4)-3.41%
Max Revenue beat(4)12.41%
Revenue beat(8)6
Avg Revenue beat(8)5.92%
Revenue beat(12)8
Avg Revenue beat(12)5.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.86%
PT rev (3m)0.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-11.32%
EPS NY rev (3m)-11.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.48%
Revenue NY rev (3m)0.48%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.12 | ||
| Fwd PE | 28.01 | ||
| P/S | 0.79 | ||
| P/FCF | 4.95 | ||
| P/OCF | 3.19 | ||
| P/B | 1.3 | ||
| P/tB | 1.88 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.34
EY3.43%
EPS(NY)0.35
Fwd EY3.57%
FCF(TTM)2
FCFY20.2%
OCF(TTM)3.11
OCFY31.39%
SpS12.59
BVpS7.64
TBVpS5.28
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.64
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.9% | ||
| ROE | 4.18% | ||
| ROCE | 5.81% | ||
| ROIC | 4.59% | ||
| ROICexc | 4.59% | ||
| ROICexgc | 5.63% | ||
| OM | 5.9% | ||
| PM (TTM) | 2.54% | ||
| GM | 52.66% | ||
| FCFM | 15.88% |
ROA(3y)9.48%
ROA(5y)5.16%
ROE(3y)16.66%
ROE(5y)5.67%
ROIC(3y)3.35%
ROIC(5y)N/A
ROICexc(3y)5.28%
ROICexc(5y)N/A
ROICexgc(3y)7.11%
ROICexgc(5y)N/A
ROCE(3y)4.24%
ROCE(5y)N/A
ROICexgc growth 3Y-24.37%
ROICexgc growth 5Y-2.89%
ROICexc growth 3Y-22.34%
ROICexc growth 5Y-2.83%
OM growth 3Y-39.59%
OM growth 5Y-6.37%
PM growth 3Y-42.29%
PM growth 5Y-3.98%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
F-Score7
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 3.47 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 8.8% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 625.94% | ||
| Current Ratio | 1.02 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 2.09 |
F-Score7
WACC6.28%
ROIC/WACC0.73
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.72%
Cap/Sales(5y)11.62%
Profit Quality(3y)203.51%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.44%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%83.33%
EPS Next Y-25.98%
EPS Next 2Y4.99%
EPS Next 3Y10.92%
EPS Next 5Y17.57%
Revenue 1Y (TTM)15%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%7.53%
Revenue Next Year15.95%
Revenue Next 2Y10.49%
Revenue Next 3Y8.64%
Revenue Next 5Y7.42%
EBIT growth 1Y36.01%
EBIT growth 3Y-19.98%
EBIT growth 5Y-6.8%
EBIT Next Year455.28%
EBIT Next 3Y83.41%
EBIT Next 5Y61.42%
FCF growth 1Y88.58%
FCF growth 3Y0.35%
FCF growth 5Y-9.05%
OCF growth 1Y62.25%
OCF growth 3Y1.9%
OCF growth 5Y-6.31%
IBERSOL SGPS SA / IBS.LS FAQ
What is the ChartMill fundamental rating of IBERSOL SGPS SA (IBS.LS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to IBS.LS.
What is the valuation status for IBS stock?
ChartMill assigns a valuation rating of 3 / 10 to IBERSOL SGPS SA (IBS.LS). This can be considered as Overvalued.
Can you provide the profitability details for IBERSOL SGPS SA?
IBERSOL SGPS SA (IBS.LS) has a profitability rating of 3 / 10.
Can you provide the financial health for IBS stock?
The financial health rating of IBERSOL SGPS SA (IBS.LS) is 4 / 10.
What is the earnings growth outlook for IBERSOL SGPS SA?
The Earnings per Share (EPS) of IBERSOL SGPS SA (IBS.LS) is expected to decline by -25.98% in the next year.